Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Go to Funding Search

Key Information

Due Date: October 1, 2024


Agency: U.S. Department of Health and Human Services (HHS)


Source: Federal


Funding Category:

Health & Human Services

Funding Amount: Not Specified


Funding Type: Grant


Match Required: No


Contact Info: grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.

Overview

The Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research is a Notice of Funding Opportunity (NOFO). It invites applications for grants that propose exploratory research projects. These projects should focus on the advancement and validation of emerging technologies. These technologies should provide unique abilities to target, probe, or assess molecular and cellular features of cancer biology for the purposes of basic or clinical cancer research.

This NOFO is specifically interested in R33 applications, where the technology or method in question has already demonstrated significant feasibility, supported by preliminary data. However, these technologies likely still need more development and stringent validation to garner acceptance and adoption by the wider research community.

Successful applications must show the potential to speed up and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, control, epidemiology. They could also address issues related to cancer health disparities.

While the technologies proposed for development should have the potential for widespread use, the focus must be on improving molecular and/or cellular characterisations of cancer. Projects that propose to use existing technologies where the innovation lies in the biological or clinical target/question are not appropriate for this NOFO and will not be considered.

This funding opportunity is part of the broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.

Show More

Key Dates

Open Date: November 29, 2023


Application Due Date: October 1, 2024


Estimated Award Date: Not Specified

Additional Details

Eligible Activities

  • Research and Development

Eligible Applicants

  • State governments
  • County governments
  • City, village or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Private institutions of higher education
  • Small businesses

Search MI Funding Hub

NOTE: Site search does not include grant search. See Find Funding page for grant searching.